# Ocular Surface Disease Changes After iStent or iStent Inject Implantation With Phacoemulsification

> **NCT04452279** · NA · COMPLETED · sponsor: **Vance Thompson Vision** · enrollment: 47 (actual)

## Conditions studied

- Ocular Surface Disease
- Glaucoma, Open-Angle

## Interventions

- **DEVICE:** iStent or iStent inject implantation with concomitant cataract surgery

## Key facts

- **NCT ID:** NCT04452279
- **Lead sponsor:** Vance Thompson Vision
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-01
- **Primary completion:** 2019-03-01
- **Final completion:** 2019-08-15
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2020-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04452279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04452279, "Ocular Surface Disease Changes After iStent or iStent Inject Implantation With Phacoemulsification". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04452279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*